Erratum: Making progress in treating multiple myeloma with total therapies: issue of complete remission and more

Article metrics

Correction to: Leukemia advance online publication, 28 February 2008; doi:10.1038/leu.2008.40

Since the publication of this paper, it has been identified by the authors that there is an error in the spelling of a word in the title of the bottom left hand graph of Figure 1.

Figure 1
figure1

Clinical outcomes of patients treated with total therapies (TT1, TT2 and TT3). Given are Kaplan–Meier plots of patients treated with TT1 (gold), TT2 without thalidomide (green), TT2 with thalidomide (red) and TT3 (blue). The four panels depict overall survival (top left), event-free survival (top right), time to stringently defined complete remission (s-CR; bottom left) and duration of s-CR from its onset (bottom right). The progressive improvement in the four clinical end points is readily appreciated with the transition from TT1 to TT2 to TT3. The plateau in the CR duration curve for TT1 from 10 years onward (bottom right panel, gold) is consistent with cure.

The correct Figure 1 is shown below.

The authors apologize for any inconvenience caused.

Additional information

The online version of the original article can be found at 10.1038/leu.2008.40

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Barlogie, B., van Rhee, F., Shaughnessy, J. et al. Erratum: Making progress in treating multiple myeloma with total therapies: issue of complete remission and more. Leukemia 22, 1650 (2008) doi:10.1038/leu.2008.86

Download citation